ANTARES PHARMA WKN: 903128 ISIN: US0366421065 Kürzel: ATRS Forum: Aktien Thema: Hauptdiskussion
5,25 EUR
±0,00 %±0,00
24. May, 10:31:31 Uhr,
Berlin
Kommentare 166
Summer.76,
08.11.2021 21:40 Uhr
0
https://finance.yahoo.com/news/lpcn-antares-agreement-nash-fast-131800309.html
Summer.76,
04.11.2021 15:51 Uhr
0
Antares Pharma Reports Third Quarter 2021 Financial and Operating Results
https://www.globenewswire.com/news-release/2021/11/04/2327256/35385/en/Antares-Pharma-Reports-Third-Quarter-2021-Financial-and-Operating-Results.html
Increased Revenue 20% Year-Over-Year to $48.2 Million
Net Income of $5.4 Million, or $0.03 Per Basic and Diluted Earnings Per Share
Summer.76,
03.11.2021 7:47 Uhr
0
Antares Pharma Enters Into Credit Agreement For Credit Facilities Of Up To $40 Million
https://last10k.com/sec-filings/atrs/0001016169-21-000034.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=atrs
Summer.76,
18.10.2021 17:39 Uhr
0
Antares Pharma Enters into Exclusive License Agreement With Lipocine for TLANDO® in U.S.
https://finance.yahoo.com/news/antares-pharma-enters-exclusive-license-110000356.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACmcGvCVMgXvJisyH7dENdV43bZ9G9OSnQ1kKolpY7XMcXw_pP1W507Dyb9F7Q1crjWuV7kbV-hAr1VMpRk1YIqYv1GmCx7S1jNC0HOwRHg58A3uV1qMVHt8eWMl_RM62gozApJBgLrzIrSagRGR1HZXr3s1v92xV9vwlDNA9Eo4
Summer.76,
30.09.2021 17:33 Uhr
0
Antares Pharma Initiates Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
https://www.globenewswire.com/news-release/2021/09/30/2306251/35385/en/Antares-Pharma-Initiates-Phase-I-Study-For-ATRS-1902-For-Adrenal-Crisis-Rescue.html
Pharmacokinetic data results expected in 1Q 2022
Summer.76,
05.08.2021 14:49 Uhr
0
Antares Pharma Reports Second Quarter 2021 Financial and Operating Results
https://www.globenewswire.com/news-release/2021/08/05/2275394/35385/en/Antares-Pharma-Reports-Second-Quarter-2021-Financial-and-Operating-Results.html
Increased Revenue 39% Year-Over-Year to $45.0 Million
Doubled Net Income to $4.4 Million, or $0.03 Per Basic and Diluted Earnings Per Share
...
Summer.76,
22.07.2021 17:03 Uhr
0
Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue
https://www.globenewswire.com/news-release/2021/07/22/2267319/35385/en/Antares-Pharma-Announces-FDA-Acceptance-of-IND-Application-for-ATRS-1902-for-Adrenal-Crisis-Rescue.html
Trader40,
17.07.2021 19:32 Uhr
0
Bin hier auch mal drin.
Summer.76,
28.06.2021 16:33 Uhr
0
Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel for Acute Myocardial Infarction
https://finance.yahoo.com/news/antares-pharma-announces-partner-idorsia-123000136.html
Summer.76,
22.06.2021 15:25 Uhr
0
Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis Rescue
https://www.globenewswire.com/news-release/2021/06/22/2251054/35385/en/Antares-Pharma-Announces-Submission-of-IND-Application-for-ATRS-1902-for-Adrenal-Crisis-Rescue.html
Summer.76,
10.05.2021 18:55 Uhr
0
https://clinicaltrials.gov/ct2/show/NCT04879589
Phase 1 Study of ATRS-2002 in Healthy Male Adults
Summer.76,
02.03.2021 13:20 Uhr
0
Antares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results
https://www.globenewswire.com/news-release/2021/03/02/2185091/0/en/Antares-Pharma-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-and-Operating-Results.html
Full-Year 2020 Revenue Increases 21% Year-Over-Year to $149.6 Million
Full-Year 2020 Net Income Before Income Taxes of $9.9 Million, or $0.06 per Share
Full-Year 2020 Net Income of $56.2 Million, including a Net Tax Benefit of $46.3 million
...
Karmate1,
20.02.2021 7:44 Uhr
0
Watchliste aufgenommen
Karmate1,
20.02.2021 7:44 Uhr
0
👀
Yakuzzi05,
19.02.2021 9:46 Uhr
0
Bin heute eingestiegen, scheint aber ruhig zu sein hier!
Summer.76,
11.01.2021 15:37 Uhr
0
Antares Pharma Announces Full-Year 2021 Revenue Guidance of $175-200 Million
https://www.globenewswire.com/news-release/2021/01/11/2156237/0/en/Antares-Pharma-Announces-Full-Year-2021-Revenue-Guidance-of-175-200-Million.html
Company updates full-year 2020 revenue guidance to $145-150 million
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | ASPENBIO Hauptdiskussion | +2,33 % | |
2 | MICROSTRATEGY Hauptdiskussion | +9,19 % | |
3 | GAMESTOP Hauptdiskussion | +25,96 % | |
4 | Aktien und Saunaclub alla Luci | ||
5 | BTC/USD Hauptdiskussion | +5,76 % | |
6 | PAYPAL Hauptdiskussion | -1,93 % | |
7 | Lilium Aktie | +1,97 % | |
8 | BED BATH & BEYOND Hauptdiskussion | -28,27 % | |
9 | Gamestop💎🙌 | +25,96 % | |
10 | AFC ENERGY Hauptdiskussion | -0,58 % | Alle Diskussionen |
Anzeige
Aktien
|
Thema | ||
---|---|---|---|
1 | ASPENBIO Hauptdiskussion | +1,92 % | |
2 | MICROSTRATEGY Hauptdiskussion | +9,35 % | |
3 | GAMESTOP Hauptdiskussion | +26,16 % | |
4 | PAYPAL Hauptdiskussion | -1,93 % | |
5 | Lilium Aktie | +1,97 % | |
6 | BED BATH & BEYOND Hauptdiskussion | -28,27 % | |
7 | Gamestop💎🙌 | +26,16 % | |
8 | AFC ENERGY Hauptdiskussion | -0,58 % | |
9 | Jaguar Health für Investierte und Interessierte | +9,11 % | |
10 | TUPPERWARE Hauptdiskussion | +22,22 % | Alle Diskussionen |